Cargando…
Recombinant TSR1 of ADAMTS5 Suppresses Melanoma Growth in Mice via an Anti-angiogenic Mechanism
Inhibiting tumor angiogenesis is a well-established approach for anticancer therapeutic development. A Disintegrin-like and Metalloproteinase with ThromboSpondin Motifs 5 (ADAMTS5) is a secreted matrix metalloproteinase in the ADAMTS family that also functions as an anti-angiogenic/anti-tumorigenic...
Autores principales: | Renganathan, Bhuvanasundar, Durairaj, Vinoth, Kirman, Dogan Can, Esubonteng, Paa Kow A., Ang, Swee Kim, Ge, Ruowen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6025205/ https://www.ncbi.nlm.nih.gov/pubmed/29891754 http://dx.doi.org/10.3390/cancers10060192 |
Ejemplares similares
-
Cell surface nucleolin is a novel ADAMTS5 receptor mediating endothelial cell apoptosis
por: Kirman, Dogan Can, et al.
Publicado: (2022) -
TSR@ISOLDE Workshop
Publicado: (2014) -
A New Perspective on Transcriptional System Regulation (TSR): Towards TSR Profiling
por: Fehrmann, Rudolf S. N., et al.
Publicado: (2008) -
AAV-Vectored Expression of the Vascular Normalizing Agents 3TSR and Fc3TSR, and the Anti-Angiogenic Bevacizumab Extends Survival in a Murine Model of End-Stage Epithelial Ovarian Carcinoma
por: Stegelmeier, Ashley A., et al.
Publicado: (2022) -
TSR - Inauguration LEP: 2
Publicado: (1989)